The Market Reports

Index

1 Drug Eluting Stents(DES) Market Overview
1.1 Product Overview and Scope of Drug Eluting Stents(DES)
1.2 Drug Eluting Stents(DES) Segment by Materials
1.2.1 Global Drug Eluting Stents(DES) Sales Growth Rate Comparison by Materials (2021-2027)
1.2.2 Cobalt-chromium Alloy Stents
1.2.3 Magnesium Alloy Stents
1.2.4 Tyrosine Polycarbonate Stents
1.2.5 Nitinol Stents
1.2.6 Platinum Chromium Alloy Stents
1.2.7 Stainless Steel Stents
1.2.8 Other Materials
1.3 Drug Eluting Stents(DES) Segment by Application
1.3.1 Global Drug Eluting Stents(DES) Sales Comparison by Application: (2021-2027)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Global Drug Eluting Stents(DES) Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Stents(DES) Revenue 2016-2027
1.4.2 Global Drug Eluting Stents(DES) Sales 2016-2027
1.4.3 Drug Eluting Stents(DES) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Drug Eluting Stents(DES) Market Competition by Manufacturers
2.1 Global Drug Eluting Stents(DES) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drug Eluting Stents(DES) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drug Eluting Stents(DES) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drug Eluting Stents(DES) Manufacturing Sites, Area Served, Product Type
2.5 Drug Eluting Stents(DES) Market Competitive Situation and Trends
2.5.1 Drug Eluting Stents(DES) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug Eluting Stents(DES) Players Market Share by Revenue
2.5.3 Global Drug Eluting Stents(DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Drug Eluting Stents(DES) Retrospective Market Scenario by Region
3.1 Global Drug Eluting Stents(DES) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Drug Eluting Stents(DES) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Drug Eluting Stents(DES) Market Facts & Figures by Country
3.3.1 North America Drug Eluting Stents(DES) Sales by Country
3.3.2 North America Drug Eluting Stents(DES) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug Eluting Stents(DES) Market Facts & Figures by Country
3.4.1 Europe Drug Eluting Stents(DES) Sales by Country
3.4.2 Europe Drug Eluting Stents(DES) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug Eluting Stents(DES) Market Facts & Figures by Region
3.5.1 Asia Pacific Drug Eluting Stents(DES) Sales by Region
3.5.2 Asia Pacific Drug Eluting Stents(DES) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Drug Eluting Stents(DES) Market Facts & Figures by Country
3.6.1 Latin America Drug Eluting Stents(DES) Sales by Country
3.6.2 Latin America Drug Eluting Stents(DES) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug Eluting Stents(DES) Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug Eluting Stents(DES) Sales by Country
3.7.2 Middle East and Africa Drug Eluting Stents(DES) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Drug Eluting Stents(DES) Historic Market Analysis by Materials
4.1 Global Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
4.2 Global Drug Eluting Stents(DES) Revenue Market Share by Materials (2016-2021)
4.3 Global Drug Eluting Stents(DES) Price by Materials (2016-2021)

5 Global Drug Eluting Stents(DES) Historic Market Analysis by Application
5.1 Global Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
5.2 Global Drug Eluting Stents(DES) Revenue Market Share by Application (2016-2021)
5.3 Global Drug Eluting Stents(DES) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abbott Vascular
6.1.1 Abbott Vascular Corporation Information
6.1.2 Abbott Vascular Description and Business Overview
6.1.3 Abbott Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Vascular Drug Eluting Stents(DES) Product Portfolio
6.1.5 Abbott Vascular Recent Developments/Updates
6.2 Advantec Vascular
6.2.1 Advantec Vascular Corporation Information
6.2.2 Advantec Vascular Description and Business Overview
6.2.3 Advantec Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Advantec Vascular Drug Eluting Stents(DES) Product Portfolio
6.2.5 Advantec Vascular Recent Developments/Updates
6.3 B.Braun Melsengen AG
6.3.1 B.Braun Melsengen AG Corporation Information
6.3.2 B.Braun Melsengen AG Description and Business Overview
6.3.3 B.Braun Melsengen AG Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 B.Braun Melsengen AG Drug Eluting Stents(DES) Product Portfolio
6.3.5 B.Braun Melsengen AG Recent Developments/Updates
6.4 Biosensors
6.4.1 Biosensors Corporation Information
6.4.2 Biosensors Description and Business Overview
6.4.3 Biosensors Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biosensors Drug Eluting Stents(DES) Product Portfolio
6.4.5 Biosensors Recent Developments/Updates
6.5 Biotronik
6.5.1 Biotronik Corporation Information
6.5.2 Biotronik Description and Business Overview
6.5.3 Biotronik Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biotronik Drug Eluting Stents(DES) Product Portfolio
6.5.5 Biotronik Recent Developments/Updates
6.6 Blue Medical
6.6.1 Blue Medical Corporation Information
6.6.2 Blue Medical Description and Business Overview
6.6.3 Blue Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Blue Medical Drug Eluting Stents(DES) Product Portfolio
6.6.5 Blue Medical Recent Developments/Updates
6.7 Boston Scientific
6.6.1 Boston Scientific Corporation Information
6.6.2 Boston Scientific Description and Business Overview
6.6.3 Boston Scientific Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Boston Scientific Drug Eluting Stents(DES) Product Portfolio
6.7.5 Boston Scientific Recent Developments/Updates
6.8 DISA Vascular
6.8.1 DISA Vascular Corporation Information
6.8.2 DISA Vascular Description and Business Overview
6.8.3 DISA Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 DISA Vascular Drug Eluting Stents(DES) Product Portfolio
6.8.5 DISA Vascular Recent Developments/Updates
6.9 Essen
6.9.1 Essen Corporation Information
6.9.2 Essen Description and Business Overview
6.9.3 Essen Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Essen Drug Eluting Stents(DES) Product Portfolio
6.9.5 Essen Recent Developments/Updates
6.10 Medtronic Vascular
6.10.1 Medtronic Vascular Corporation Information
6.10.2 Medtronic Vascular Description and Business Overview
6.10.3 Medtronic Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Medtronic Vascular Drug Eluting Stents(DES) Product Portfolio
6.10.5 Medtronic Vascular Recent Developments/Updates
6.11 MicroPort Medical
6.11.1 MicroPort Medical Corporation Information
6.11.2 MicroPort Medical Drug Eluting Stents(DES) Description and Business Overview
6.11.3 MicroPort Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 MicroPort Medical Drug Eluting Stents(DES) Product Portfolio
6.11.5 MicroPort Medical Recent Developments/Updates
6.12 MIV Therapeutics
6.12.1 MIV Therapeutics Corporation Information
6.12.2 MIV Therapeutics Drug Eluting Stents(DES) Description and Business Overview
6.12.3 MIV Therapeutics Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 MIV Therapeutics Drug Eluting Stents(DES) Product Portfolio
6.12.5 MIV Therapeutics Recent Developments/Updates
6.13 Orbusneich
6.13.1 Orbusneich Corporation Information
6.13.2 Orbusneich Drug Eluting Stents(DES) Description and Business Overview
6.13.3 Orbusneich Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Orbusneich Drug Eluting Stents(DES) Product Portfolio
6.13.5 Orbusneich Recent Developments/Updates
6.14 Promed Medical
6.14.1 Promed Medical Corporation Information
6.14.2 Promed Medical Drug Eluting Stents(DES) Description and Business Overview
6.14.3 Promed Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Promed Medical Drug Eluting Stents(DES) Product Portfolio
6.14.5 Promed Medical Recent Developments/Updates
6.15 Relisys Medical
6.15.1 Relisys Medical Corporation Information
6.15.2 Relisys Medical Drug Eluting Stents(DES) Description and Business Overview
6.15.3 Relisys Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Relisys Medical Drug Eluting Stents(DES) Product Portfolio
6.15.5 Relisys Medical Recent Developments/Updates
6.16 Reva Medical
6.16.1 Reva Medical Corporation Information
6.16.2 Reva Medical Drug Eluting Stents(DES) Description and Business Overview
6.16.3 Reva Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Reva Medical Drug Eluting Stents(DES) Product Portfolio
6.16.5 Reva Medical Recent Developments/Updates
6.17 Sahajanand
6.17.1 Sahajanand Corporation Information
6.17.2 Sahajanand Drug Eluting Stents(DES) Description and Business Overview
6.17.3 Sahajanand Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Sahajanand Drug Eluting Stents(DES) Product Portfolio
6.17.5 Sahajanand Recent Developments/Updates
6.18 Sino Medical
6.18.1 Sino Medical Corporation Information
6.18.2 Sino Medical Drug Eluting Stents(DES) Description and Business Overview
6.18.3 Sino Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Sino Medical Drug Eluting Stents(DES) Product Portfolio
6.18.5 Sino Medical Recent Developments/Updates
6.19 Sorin
6.19.1 Sorin Corporation Information
6.19.2 Sorin Drug Eluting Stents(DES) Description and Business Overview
6.19.3 Sorin Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Sorin Drug Eluting Stents(DES) Product Portfolio
6.19.5 Sorin Recent Developments/Updates
6.20 Terumo Medical
6.20.1 Terumo Medical Corporation Information
6.20.2 Terumo Medical Drug Eluting Stents(DES) Description and Business Overview
6.20.3 Terumo Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Terumo Medical Drug Eluting Stents(DES) Product Portfolio
6.20.5 Terumo Medical Recent Developments/Updates

7 Drug Eluting Stents(DES) Manufacturing Cost Analysis
7.1 Drug Eluting Stents(DES) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug Eluting Stents(DES)
7.4 Drug Eluting Stents(DES) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug Eluting Stents(DES) Distributors List
8.3 Drug Eluting Stents(DES) Customers

9 Drug Eluting Stents(DES) Market Dynamics
9.1 Drug Eluting Stents(DES) Industry Trends
9.2 Drug Eluting Stents(DES) Growth Drivers
9.3 Drug Eluting Stents(DES) Market Challenges
9.4 Drug Eluting Stents(DES) Market Restraints

10 Global Market Forecast
10.1 Drug Eluting Stents(DES) Market Estimates and Projections by Materials
10.1.1 Global Forecasted Sales of Drug Eluting Stents(DES) by Materials (2022-2027)
10.1.2 Global Forecasted Revenue of Drug Eluting Stents(DES) by Materials (2022-2027)
10.2 Drug Eluting Stents(DES) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug Eluting Stents(DES) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drug Eluting Stents(DES) by Application (2022-2027)
10.3 Drug Eluting Stents(DES) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug Eluting Stents(DES) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drug Eluting Stents(DES) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Drug Eluting Stents(DES) Sales (K Units) Growth Rate Comparison by Materials (2021-2027)
Table 2. Global Drug Eluting Stents(DES) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drug Eluting Stents(DES) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drug Eluting Stents(DES) Covered in This Study
Table 5. Global Drug Eluting Stents(DES) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drug Eluting Stents(DES) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Drug Eluting Stents(DES) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drug Eluting Stents(DES) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drug Eluting Stents(DES) Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drug Eluting Stents(DES) Manufacturing Sites and Area Served
Table 11. Manufacturers Drug Eluting Stents(DES) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug Eluting Stents(DES) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Stents(DES) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug Eluting Stents(DES) Sales by Region (2016-2021) & (K Units)
Table 16. Global Drug Eluting Stents(DES) Sales Market Share by Region (2016-2021)
Table 17. Global Drug Eluting Stents(DES) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drug Eluting Stents(DES) Sales by Country (2016-2021) & (K Units)
Table 19. North America Drug Eluting Stents(DES) Sales Market Share by Country (2016-2021)
Table 20. North America Drug Eluting Stents(DES) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drug Eluting Stents(DES) Revenue Market Share by Country (2016-2021)
Table 22. Europe Drug Eluting Stents(DES) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drug Eluting Stents(DES) Sales Market Share by Country (2016-2021)
Table 24. Europe Drug Eluting Stents(DES) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drug Eluting Stents(DES) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drug Eluting Stents(DES) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drug Eluting Stents(DES) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drug Eluting Stents(DES) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drug Eluting Stents(DES) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drug Eluting Stents(DES) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drug Eluting Stents(DES) Sales Market Share by Country (2016-2021)
Table 32. Latin America Drug Eluting Stents(DES) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drug Eluting Stents(DES) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drug Eluting Stents(DES) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drug Eluting Stents(DES) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drug Eluting Stents(DES) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drug Eluting Stents(DES) Revenue Market Share by Country (2016-2021)
Table 38. Global Drug Eluting Stents(DES) Sales (K Units) by Materials (2016-2021)
Table 39. Global Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
Table 40. Global Drug Eluting Stents(DES) Revenue (Million US$) by Materials (2016-2021)
Table 41. Global Drug Eluting Stents(DES) Revenue Share by Materials (2016-2021)
Table 42. Global Drug Eluting Stents(DES) Price (USD/Unit) by Materials (2016-2021)
Table 43. Global Drug Eluting Stents(DES) Sales (K Units) by Application (2016-2021)
Table 44. Global Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
Table 45. Global Drug Eluting Stents(DES) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drug Eluting Stents(DES) Revenue Share by Application (2016-2021)
Table 47. Global Drug Eluting Stents(DES) Price (USD/Unit) by Application (2016-2021)
Table 48. Abbott Vascular Corporation Information
Table 49. Abbott Vascular Description and Business Overview
Table 50. Abbott Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Abbott Vascular Drug Eluting Stents(DES) Product
Table 52. Abbott Vascular Recent Developments/Updates
Table 53. Advantec Vascular Corporation Information
Table 54. Advantec Vascular Description and Business Overview
Table 55. Advantec Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Advantec Vascular Drug Eluting Stents(DES) Product
Table 57. Advantec Vascular Recent Developments/Updates
Table 58. B.Braun Melsengen AG Corporation Information
Table 59. B.Braun Melsengen AG Description and Business Overview
Table 60. B.Braun Melsengen AG Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. B.Braun Melsengen AG Drug Eluting Stents(DES) Product
Table 62. B.Braun Melsengen AG Recent Developments/Updates
Table 63. Biosensors Corporation Information
Table 64. Biosensors Description and Business Overview
Table 65. Biosensors Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Biosensors Drug Eluting Stents(DES) Product
Table 67. Biosensors Recent Developments/Updates
Table 68. Biotronik Corporation Information
Table 69. Biotronik Description and Business Overview
Table 70. Biotronik Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Biotronik Drug Eluting Stents(DES) Product
Table 72. Biotronik Recent Developments/Updates
Table 73. Blue Medical Corporation Information
Table 74. Blue Medical Description and Business Overview
Table 75. Blue Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Blue Medical Drug Eluting Stents(DES) Product
Table 77. Blue Medical Recent Developments/Updates
Table 78. Boston Scientific Corporation Information
Table 79. Boston Scientific Description and Business Overview
Table 80. Boston Scientific Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Boston Scientific Drug Eluting Stents(DES) Product
Table 82. Boston Scientific Recent Developments/Updates
Table 83. DISA Vascular Corporation Information
Table 84. DISA Vascular Description and Business Overview
Table 85. DISA Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. DISA Vascular Drug Eluting Stents(DES) Product
Table 87. DISA Vascular Recent Developments/Updates
Table 88. Essen Corporation Information
Table 89. Essen Description and Business Overview
Table 90. Essen Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Essen Drug Eluting Stents(DES) Product
Table 92. Essen Recent Developments/Updates
Table 93. Medtronic Vascular Corporation Information
Table 94. Medtronic Vascular Description and Business Overview
Table 95. Medtronic Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Medtronic Vascular Drug Eluting Stents(DES) Product
Table 97. Medtronic Vascular Recent Developments/Updates
Table 98. MicroPort Medical Corporation Information
Table 99. MicroPort Medical Description and Business Overview
Table 100. MicroPort Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. MicroPort Medical Drug Eluting Stents(DES) Product
Table 102. MicroPort Medical Recent Developments/Updates
Table 103. MIV Therapeutics Corporation Information
Table 104. MIV Therapeutics Description and Business Overview
Table 105. MIV Therapeutics Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. MIV Therapeutics Drug Eluting Stents(DES) Product
Table 107. MIV Therapeutics Recent Developments/Updates
Table 108. Orbusneich Corporation Information
Table 109. Orbusneich Description and Business Overview
Table 110. Orbusneich Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Orbusneich Drug Eluting Stents(DES) Product
Table 112. Orbusneich Recent Developments/Updates
Table 113. Promed Medical Corporation Information
Table 114. Promed Medical Description and Business Overview
Table 115. Promed Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Promed Medical Drug Eluting Stents(DES) Product
Table 117. Promed Medical Recent Developments/Updates
Table 118. Relisys Medical Corporation Information
Table 119. Relisys Medical Description and Business Overview
Table 120. Relisys Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Relisys Medical Drug Eluting Stents(DES) Product
Table 122. Relisys Medical Recent Developments/Updates
Table 123. Reva Medical Corporation Information
Table 124. Reva Medical Description and Business Overview
Table 125. Reva Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Reva Medical Drug Eluting Stents(DES) Product
Table 127. Reva Medical Recent Developments/Updates
Table 128. Sahajanand Corporation Information
Table 129. Sahajanand Description and Business Overview
Table 130. Sahajanand Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Sahajanand Drug Eluting Stents(DES) Product
Table 132. Sahajanand Recent Developments/Updates
Table 133. Sino Medical Corporation Information
Table 134. Sino Medical Description and Business Overview
Table 135. Sino Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Sino Medical Drug Eluting Stents(DES) Product
Table 137. Sino Medical Recent Developments/Updates
Table 138. Sorin Corporation Information
Table 139. Sorin Description and Business Overview
Table 140. Sorin Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Sorin Drug Eluting Stents(DES) Product
Table 142. Sorin Recent Developments/Updates
Table 143. Terumo Medical Corporation Information
Table 144. Terumo Medical Description and Business Overview
Table 145. Terumo Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Terumo Medical Drug Eluting Stents(DES) Product
Table 147. Terumo Medical Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Drug Eluting Stents(DES) Distributors List
Table 151. Drug Eluting Stents(DES) Customers List
Table 152. Drug Eluting Stents(DES) Market Trends
Table 153. Drug Eluting Stents(DES) Growth Drivers
Table 154. Drug Eluting Stents(DES) Market Challenges
Table 155. Drug Eluting Stents(DES) Market Restraints
Table 156. Global Drug Eluting Stents(DES) Sales Forecast by Materials (2022-2027) & (K Units)
Table 157. Global Drug Eluting Stents(DES) Sales Market Share Forecast by Materials (2022-2027)
Table 158. Global Drug Eluting Stents(DES) Revenue Forecast by Materials (2022-2027) & (US$ Million)
Table 159. Global Drug Eluting Stents(DES) Revenue Market Share Forecast by Materials (2022-2027)
Table 160. Global Drug Eluting Stents(DES) Sales Forecast by Application (2022-2027) & (K Units)
Table 161. Global Drug Eluting Stents(DES) Sales Market Share Forecast by Application (2022-2027)
Table 162. Global Drug Eluting Stents(DES) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 163. Global Drug Eluting Stents(DES) Revenue Market Share Forecast by Application (2022-2027)
Table 164. Global Drug Eluting Stents(DES) Sales Forecast by Region (2022-2027) & (K Units)
Table 165. Global Drug Eluting Stents(DES) Sales Market Share Forecast by Region (2022-2027)
Table 166. Global Drug Eluting Stents(DES) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 167. Global Drug Eluting Stents(DES) Revenue Market Share Forecast by Region (2022-2027)
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Eluting Stents(DES)
Figure 2. Global Drug Eluting Stents(DES) Market Share by Materials in 2020 & 2027
Figure 3. Cobalt-chromium Alloy Stents Product Picture
Figure 4. Magnesium Alloy Stents Product Picture
Figure 5. Tyrosine Polycarbonate Stents Product Picture
Figure 6. Nitinol Stents Product Picture
Figure 7. Platinum Chromium Alloy Stents Product Picture
Figure 8. Stainless Steel Stents Product Picture
Figure 9. Other Materials Product Picture
Figure 10. Global Drug Eluting Stents(DES) Market Share by Application in 2020 & 2027
Figure 11. Coronary Heart Disease
Figure 12. Clinical
Figure 13. Global Drug Eluting Stents(DES) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Drug Eluting Stents(DES) Market Size 2016-2027 (US$ Million)
Figure 15. Global Drug Eluting Stents(DES) Sales 2016-2027 (K Units)
Figure 16. Global Drug Eluting Stents(DES) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Drug Eluting Stents(DES) Sales Share by Manufacturers in 2020
Figure 18. Global Drug Eluting Stents(DES) Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Drug Eluting Stents(DES) Players: Market Share by Revenue in 2020
Figure 20. Drug Eluting Stents(DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Drug Eluting Stents(DES) Sales Market Share by Region (2016-2021)
Figure 22. Global Drug Eluting Stents(DES) Sales Market Share by Region in 2020
Figure 23. Global Drug Eluting Stents(DES) Revenue Market Share by Region (2016-2021)
Figure 24. Global Drug Eluting Stents(DES) Revenue Market Share by Region in 2020
Figure 25. U.S. Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. China Taiwan Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Drug Eluting Stents(DES) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Drug Eluting Stents(DES) by Materials (2016-2021)
Figure 48. Sales Market Share of Drug Eluting Stents(DES) by Application (2016-2021)
Figure 49. Sales Market Share of Drug Eluting Stents(DES) by Application in 2020
Figure 50. Revenue Share of Drug Eluting Stents(DES) by Application (2016-2021)
Figure 51. Revenue Share of Drug Eluting Stents(DES) by Application in 2020
Figure 52. Manufacturing Cost Structure of Drug Eluting Stents(DES)
Figure 53. Manufacturing Process Analysis of Drug Eluting Stents(DES)
Figure 54. Drug Eluting Stents(DES) Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed